Bearish
Pfizer's stock drops 1.9% to $24.53 amid cautious analyst outlook
Pfizer's stock declined by 1.9% to $24.53, influenced by cautious analyst perspectives and recent company developments.
Key points
- Analysts maintain a 'Hold' rating with an average price target of $28.50, indicating limited short-term upside.
- Pfizer's recent dividend announcement of $0.43 per share reflects a commitment to shareholder returns.
- The company reaffirmed its 2026 financial guidance, projecting revenues between $59.5 billion and $62.5 billion.
Sources
AI-generated from public news sources. Not financial advice.
